Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Veracyte Inc (NQ: VCYT ) 29.77 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Veracyte Inc < Previous 1 2 3 4 Next > Thermo Fisher Scientific Stock Sees RS Rating Jump To 81 August 13, 2024 Thermo Fisher Scientific stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 77 to 81. Via Investor's Business Daily Lumen Tech & Upstart Are Among Top 7 Mid Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio? August 11, 2024 Lumen, Upstart, ADMA, Sweetgreen, Veracyte, Clear Secure, and Core Scientific were best performers last week. Did you invest in them? Via Benzinga Diagnostic Tests Maker Veracyte's Q2 Is 'All-Around Very Good Quarter': Analysts Maintain Bullish View August 07, 2024 Veracyte reports Q2 sales of $114.43M, a 27% increase year over year, surpassing the $100.3 million consensus. Testing revenue rose 31% to $107 million, driven by strong performance of Decipher... Via Benzinga Shopify Posts Upbeat Earnings, Joins Axon Enterprise, Aspen Technology, Illumina, Global Payments And Other Big Stocks Moving Higher On Wednesday August 07, 2024 Via Benzinga A Glimpse Into The Expert Outlook On Veracyte Through 4 Analysts May 08, 2024 Via Benzinga Recap: Veracyte Q4 Earnings February 22, 2024 Via Benzinga Earnings Outlook For Veracyte February 21, 2024 Via Benzinga Veracyte: Q3 Earnings Insights November 07, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday August 07, 2024 Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning! Via InvestorPlace VCYT Stock Earnings: Veracyte Beats EPS, Beats Revenue for Q2 2024 August 06, 2024 VCYT stock results show that Veracyte beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace The 3 Best Personalized Nutrition Stocks to Buy Now July 24, 2024 Explore personalized nutrition stocks capitalizing on AI, machine learning and genetic profiling to provide targeted dietary solutions. Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence Trading SMID Biotech Stocks In A Volatile Market July 01, 2024 Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a... Via Talk Markets The Latest Analyst Ratings for Veracyte October 20, 2023 Via Benzinga Here's Why This Little-Known Growth Stock Is a Buy May 22, 2023 Analysts think this genomic test maker could have major upside in the next year. Via The Motley Fool Looking Into Veracyte's Return On Capital Employed May 17, 2023 Via Benzinga Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness June 10, 2024 On Monday, Cathie Wood-led Ark Invest made a significant move by reducing its holdings in Robinhood Markets Inc (NASDAQ:HOOD). This decision came amidst a period of market fluctuations and followed a... Via Benzinga VCYT Stock Earnings: Veracyte Beats EPS, Beats Revenue for Q1 2024 May 07, 2024 VCYT stock results show that Veracyte beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Cathie Wood's Ark Invest Dumps $17M In Coinbase Shares As The Exchange Grappled With Disruption Amid Bitcoin Rally February 28, 2024 On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling over $17 million worth of Coinbase Global Inc (NASDAQ:COIN) shares. Via Benzinga Cathie Wood's Ark Invest Sheds $9.3M Worth Of Coinbase Shares Amid Bitcoin Rally — Robinhood Stock Also Sold February 27, 2024 On Tuesday, Cathie Wood-led Ark Invest adjusted its portfolio, making significant trades. Via Benzinga Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed February 26, 2024 On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such as Robinhood Markets Inc (NASDAQ:HOOD) and Coinbase Global Inc (NASDAQ: Via Benzinga 7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff February 26, 2024 Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off. Via InvestorPlace Cathie Wood's Ark Invest Buys Over $92M Worth Of ProShares Bitcoin ETF, Sells Coinbase, Block And Palantir Shares December 27, 2023 On Wednesday, Cathie Wood-led Ark Invest made a significant move in the cryptocurrency space, purchasing over $92 million worth of ProShares Bitcoin Strategy ETF (NYSE:BITO). Via Benzinga Topics ETFs Are You A Trader Or Investor: Biotech Momentum Is Picking Up November 20, 2023 ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market. Via Talk Markets Topics ETFs Earnings Scheduled For February 22, 2024 February 22, 2024 Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million. Via Benzinga Earnings Scheduled For November 7, 2023 November 07, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. Via Benzinga 7 Undervalued Stocks That Analysts Love Right Now October 26, 2023 With many investors concerned about what may lie ahead in the market, these potentially de-risked undervalued stocks may be ideal. Via InvestorPlace Veracyte Stock Is Volatile After-Hours - Here's Why October 04, 2023 Veracyte, Inc. (NASDAQ: VCYT) shares are volatile after-hours on Wednesday after the company announced that new data from a phase 3 trial validates the value of the Decipher Prostate Genomic Classifier... Via Benzinga Is This Underfollowed Genetic Diagnostics Stock a Buy for Growth Investors? September 02, 2023 The genetic test maker is rapidly increasing test volumes. Via The Motley Fool Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom July 08, 2023 AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider. Via InvestorPlace Market Mixes It Up With A Broad Rally June 05, 2023 Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive. Via Talk Markets < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.